SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2015 on Thursday, November 5, 2015, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Thursday, November 5, 2015, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and operations.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
